Rafael Holdings RFL
NYSE RFL
$1.33 +0.04 (+2.77%)
As of: Oct 21, 2026 · 3:59 PM EDT

Rafael Holdings (RFL) Operating Margin (2017 - 2026)

Updated

Rafael Holdings (RFL) reported Operating Margin of -3837.99% for fiscal Q3 2026 (quarter ended Apr 30, 2026), down 2204.56 percentage points from -1633.43% a year earlier and down 683.96 percentage points from the prior quarter.

Analysis

Rafael Holdings (RFL) Operating Margin (2017 - 2026) Analysis & Trends

Over the twelve months ended Apr 30, 2026, Rafael Holdings' Operating Margin came in at -3717.24%, down 952.08 percentage points year-over-year; for FY2025 (ended Jul 31, 2025), it came in at -3179.83%, up 12931.16 percentage points from FY2024.

  • Operating Margin has a five-year change of -3007.42 percentage points (FY2020 to FY2025).
  • By fiscal year, Operating Margin came in at -16110.99% in FY2024 (-10719.23 pp), -5391.76% in FY2023 (+9358.73 pp), -14750.49% in FY2022 (-11234.40 pp) and -3516.08% in FY2021 (-3343.68 pp).
  • Five-year quarterly Operating Margin spans a low of -27726.49% in fiscal Q3 2024 and a high of -1633.43% in fiscal Q3 2025.
  • Year over year, Operating Margin gained in four of the last eight quarters, with an average year-over-year change of +3121.05 percentage points.
  • The high point for year-over-year Operating Margin in five years was fiscal Q3 2025 (a gain of 26093.06 percentage points); the low point was fiscal Q1 2022 (a drop of 25699.56 percentage points).
  • Per Business Quant data, the three fiscal quarters before Q3 2026 came in at -3154.03% (Q2 2026), -4225.42% (Q1 2026) and -3646.57% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.21%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 37.86%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 20.57%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -133.21%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 28.37%
10 Rafael Holdings 65.83 Mn -100.78 Mn 163,000.00 -3,837.99%
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 -3,837.99%
Jan 31, 2026 -3,154.03%
Oct 31, 2025 -4,225.42%
Jul 31, 2025 -3,646.57%
Apr 30, 2025 -1,633.43%
Jan 31, 2025 -8,622.08%
Oct 31, 2024 -3,003.13%
Jul 31, 2024 -2,330.30%
Apr 30, 2024 -27,726.49%
Jan 31, 2024 -4,622.06%
Oct 31, 2023 -3,644.12%
Jul 31, 2023 -3,839.71%
Apr 30, 2023 -4,269.01%
Jan 31, 2023 -6,084.29%
Oct 31, 2022 -7,345.71%
Jul 31, 2022 -7,011.59%
Apr 30, 2022 -6,171.05%
Jan 31, 2022 -2,160.81%
Oct 31, 2021 -25,936.13%
Apr 30, 2021 -351.41%
API Access

Rafael Holdings Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=RFL&period=max&api_key=YOUR_API_KEY